Alio Medica Sp.J. sp. j.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2021-03-24
Registered address
ul. Górzysta 15/1, 85-167 Bydgoszcz, Poland
Electronic delivery address
AE:PL-60910-66675-TJHBW-14
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk.
From the notes
| Current income tax (CIT due) | $385,991 |
Filing timeliness
Financial statements were filed on time, on average 110 days early.
- 202510/02/2026
- 202418/03/2025
- 202304/04/2024
- 202222/03/2023
- 202117/05/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Research and experimental development in natural sciences and engineering23 / 275
Top 8.4%
Results vs industry
Revenue
This companyUSD 8.16mMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD 1.78mMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 5.99mMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 134.02kMedianUSD 281.58kAverageUSD 8.35m
Industry
Ownership
Manner of representation
1. The right to represent the company is vested in PRM DEWELOPER RUMIA spółka z ograniczoną odpowiedzialnością. 2. PRM DEWELOPER RUMIA spółka z ograniczoną odpowiedzialnością is authorised to conduct the affairs of the company.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-04-02.
43 1050 1139 1000 0090 3316 9336
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 12, 2026 | Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies | –– | Energa - Obrót S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Polpharma Biologics S.A. | $19,057,541.37 | polpharmabiologics.com | ||
| Ryvu Therapeutics S.A. | $15,633,852.34 | ryvu.com | ||
| Ardigen S.A. | $12,513,309.89 | ardigen.com | ||
| Centrum Naukowo-Badawcze Ochrony Przeciwpożarowej Im. Józefa Tuliszkowskiego - Państwowy Instytut Badawczy Research institute | $11,221,681.24 | cnbop.pl | ||
| Centrum Techniki Okrętowej S.A. | $10,041,376.36 | cto.gda.pl | ||
| Telesystem Group S.A. | $9,093,586.25 | mikroel.tech | ||
| Genomed S.A. | $7,373,750.46 | genomed.pl | ||
| Sieć Badawcza Łukasiewicz – Instytut Sztucznej Inteligencji I Cyberbezpieczeństwa Research institute | $6,514,456.26 | ai.lukasiewicz.gov.pl | ||
| SR Robotics sp. z o.o. | $4,456,035.13 | srrobotics.pl | ||
| Xtpl S.A. | $3,872,928.18 | xtpl.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-27 | Address change (Ul. Śmiechowska 2c/L24, 84-200, Wejherowo → Ul. Górzysta 15/1, 85-167, Bydgoszcz) | |
| 2026-05-27 | Name change (Prm Deweloper Rumia Spółka Z Ograniczoną Odpowiedzialnością → Alio Medica Spółka Z Ograniczoną Odpowiedzialnością Sp.j.) | |
| 2021-03-24 | Entered in the register |
FAQ
The main business activity of Alio Medica focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on March 24, 2021.
The headquarters is located at: ul. Górzysta 15, 85-167 Bydgoszcz.
The legal form of this entity is a general partnership (sp.j.).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 8,163,152, representing an increase of 318.8% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 1,778,654, meaning the company increased its profit by 355.8%.
The largest operating cost category falls under materials and energy. This category amounted to USD 5,911,751 in 2025, representing 99% of all operating expenses.
Last updated: 2026-09-02